What Has Been the Growth Trajectory for the Pre Filled Syringes Market in Recent Years?
The pre filled syringes market has seen considerable growth due to a variety of factors.
• The market size for prefilled syringes experienced quick expansion in the past few years. It's projected to escalate from $8.3 billion in 2024 to $9.46 billion in 2025, registering a compound annual growth rate (CAGR) of 14.0%.
This previously observed growth can be associated with the burgeoning development in the pharmaceutical and biotechnological sector, the enlargement of biologics and vaccines, the requirement for easy-to-use and exact drug delivery systems, the rise in home healthcare and self-treatment, and the strict regulations for drug safety and packaging.
How Does the Forecast Look for the Pre Filled Syringes Market?
The pre filled syringes market is expected to maintain its strong growth trajectory in upcoming years.
• The market of pre-filled syringes is predicted to witness a swift expansion in the upcoming years. The predicted value is set at $16.42 billion by 2029, with a compound annual growth rate (CAGR) of 14.8%.
The surge during the forecast period can be attributed to factors such as the design of pre-filled syringe solutions tailored for specific drugs, emphasis on biodegradable and sustainable materials, advancements in smart and connected syringes, growing utilization in telemedicine and telehealth, and use in long-acting injectable medications. Major trends anticipated during the forecast period are adherence to regulatory guidelines for pre-filled syringe safety, smart and connected syringes for accurate dosing, biodegradable and environmentally-friendly syringe materials, customized syringe solutions for different patient demographics, and the need for transparency and traceability in drug delivery.
What Are the Critical Driver Fuelling the Pre Filled Syringes Market's Growth?
The anticipated increase in healthcare delivered at home is set to bolster the pre-filled syringe market in the future. The term home-based health care pertains to medical treatment and support provided to patients in their residences, aiming to aid their recovery and management of illnesses in their own comfortable spaces. With the evolution of the health care system, the pre-filled syringe market is expected to grow significantly, due to facilitated precise dosage, lowered contamination risk, and increased patient compliance, thereby advancing the quality of home-based care. For instance, data from the National Association for Home Care and Hospice, a non-profit organization in the United States, addressing the needs of Americans afflicted by chronic diseases, disability, and approaching end-of-life, claimed that around 12 million Americans avail some form of home health care annually in February 2023, and this figure is predicted to rise consistently. As such, the increasing trend of healthcare at home is likely to propel the market growth in the projected period.
How Is the Pre Filled Syringes Market segmented?
The pre filled syringes market covered in this report is segmented –
1) By Type: Conventional Prefilled Syringes, Safety Prefilled Syringes
2) By Material: Glass Prefilled Syringes, Plastic Prefilled Syringes
3) By Design: Single-Chamber Prefilled Syringes, Dual- Chamber Prefilled Syringes, Customized Prefilled Syringes
4) By Application: Diabetes, Rheumatoid Arthritis, Anaphylaxis, Cancer, Thrombosis, Ophthalmology, Other Applications
Subsegments:
1) By Conventional Prefilled Syringes: Glass Prefilled Syringes, Plastic Prefilled Syringes
2) By Safety Prefilled Syringes: Retractable Needle Syringes, Non-Retractable Needle Syringes
Pre-Book The Pre Filled Syringes Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What New Trends Are Influencing the Pre Filled Syringes Market?
An increasing number of firms in the prefilled syringes market are putting their capital into next-generation prefilled syringes, enabling medical practitioners to collect and monitor data. The term "next-generation pre-filled syringes" applies to advanced syringes developed with cutting-edge technology to enhance drug delivery, boost patient safety, and provide extra characteristics such as connectivity and user-friendliness. Becton, Dickinson and Company (BD), a US-based medical technology firm, launched a next-gen glass prefillable syringe (PFS) in September 2022, which complies with more stringent standards for processability, aesthetics, integrity, and contamination, setting a new benchmark for vaccine PFS performance. In collaboration with leading pharmaceutical corporations, the revolutionary BD Effivax Glass Prefillable Syringe was conceived to meet the complex and evolving needs of vaccine manufacturing.
Who Are the Key Players in the Pre Filled Syringes Market?
Major companies operating in the pre filled syringes market include:
• Becton
• Dickinson and Company
• Gerresheimer AG
• Schott & Associates Glass Technology Laboratory
• West Pharmaceutical Services Inc.
• Baxter International
• Nipro Corporation
• Terumo Corporation
• Vetter Pharma International GmbH
• Stevanato Group SPA
• Shandong Weigao Group Medical Polymer Company Ltd.
• Novartis AG
• Catalent Inc.
• Unilife Corporation
• Eli Lilly and Company
• Bayer AG
• Pfizer Inc.
• Bristol-Myers Squibb Co.
• F. Hoffman-La Roche Ltd.
• AbbVie Inc.
• Owen Mumford Holdings Ltd.
• AptarGroup Inc.
• Medtronic Plc
• Abbott Laboratories
• Fresenius Kabi India Pvt. Ltd.
• Medical Protective Ltd.
• Mylan NV
• Elcam Medical Inc.
• YPSOMED Holding AG
• Oval Medical Technologies
• SHL Medical
• ACASI Machinery Inc.
• Bespak Holdings Ltd.
• BioPharma Solutions
• Catalent Pharma Solutions
• Credence MedSystems Inc.
• Hasemeier Inc.
• Intas Pharmaceuticals Ltd.
• Intelicure Lifesciences
• Mycoscience Labs
What Is The Most Dominant Region In The Pre Filled Syringes Market?
Europe was the largest region in the prefilled syringes market in 2024. The regions covered in the pre filled syringes market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
